
Dentists have devised a treatment to regenerate rotten teeth that could substantially reduce the need for fillings in the future. The therapy works by enhancing the natural ability of teeth to repair themselves through the activation of stem cells in the soft pulp at the centre.
Normally, this mechanism is limited to repairing small cracks and holes in dentine, the solid bulk of the tooth beneath the surface enamel. Now scientists have shown that the natural process can be enhanced using an Alzheimer’s drug, allowing the tooth’s own cells to rebuild cavities extending from the surface to the root.
Prof Paul Sharpe, who led the work at King’s College London, said: “Almost everyone on the planet has tooth decay at some time – it’s a massive volume of people being treated. We’ve deliberately tried to make something really simple, really quick and really cheap.”
Restoring the tooth’s original dentine structure is preferable because dental cements used in conventional fillings weaken the tooth, leave it prone to future infections – and inevitably erode or detach. In the case of large cavities, the tooth may eventually need to be extracted after undergoing multiple treatments. The new method, which would encourage natural tooth repair, has the potential to eliminate these issues, according to the scientists.
“The tooth is not just a lump of mineral, it’s got its own physiology. You’re replacing a living tissue with an inert cement,” said Sharpe. “Fillings work fine, but if the tooth can repair itself, surely [that’s] the best way. You’re restoring all the vitality of the tooth.”
The new treatment would not eliminate the need for the dentist’s drill, however, since decaying sections of the tooth would still need to be removed. “Sorry, you’re still going to have the drill, you can’t get away from that, I’m afraid,” said Sharpe.
The therapy relies on a drug called tideglusib, which has been assessed as a potential Alzheimer’s treatment, and which is known to be safe for clinical use. Previous work by the team has shown that the drug stimulates stem cells in the centre of the tooth, triggering them to develop into odontoblasts (specialised tooth cells) and boosting the production of dentine, allowing larger defects to be reversed. “We get more of the cells, much quicker and they are more active,” said Sharpe.
Ben Scheven, an oral cell biologist at the University of Birmingham, said that preserving the live tooth tissue was increasingly viewed as a priority. “Dentistry is not only about filling and drilling but also about keeping the teeth healthy,” he said. “Especially since it’s an accessible and cheap treatment I can imagine this being used in the clinic.”
Source: The Guardian